Overview of sessions in English

Keratomycosis is a relatively rare but sight threatening disease. In view of the changing epidemiology of this severe problem the standard of care is continuously evolving and new treatment modalities - although often considered to be controversial - have to be explored. This symposium will discuss medical as well as surgical management options of fungal corneal infections, such as the use of mono- versus combination topical therapy, the need for corneal abrasion, the concomittant use of antiinflammatory medication, as well as corneal crosslinking, lamellar corneal transplantation and bioengineered tissue.